Andrew Pollard, Director of the Oxford Vaccine Group and Chief Investigator on its COVID-19 trials, have been at the forefront of research, most significantly regarding vaccine development. The remarkable progress made by Professor Pollard and his team, captured by data published this week in the Lancet, holds out hope that an effective and safe vaccine might be available earlier than originally assumed, during 2021.
Guest: Andrew Pollard, Director of the Oxford Vaccine Group and Chief Investigator on its COVID-19 trials
Host: Narayan Lakshman, Associate Editor, The Hindu